Content |
The main articles are:
Ablation is the local destruction of a tumor without removing it. The procedure is used in the presence of several small tumors that cannot be removed surgically. Ablation techniques do not always allow you to completely get rid of cancer, but increase the chances of survival in cancer patients.
2024: Global tumor ablation equipment sales reach $1.89 billion
In 2024, the global market for tumor ablation equipment reached $1.89 billion. More than a third of global spending was in the North American region. Such data are provided in the Grand View Research review, which Zdrav.Expert reviewed in mid-September 2025.
Ablation is the destruction of the tissue of a malignant formation using a certain type of energy. There are various methods of energy ablation: hyperthermal (radiofrequency and microwave ablation, laser, ultrasound), hypothermic (cryoablation) and non-thermal (photodynamic therapy, electroporation). Advanced tumor ablation procedures tend to be performed on an outpatient basis and do not require hospitalization, reducing overall health care costs. At the same time, the recovery time of patients is accelerated.
One of the main drivers of the market is the increasing prevalence of malignancies. According to the World Health Organization (WHO), in 2022, approximately 20 million new cases of cancer and 9.7 million deaths caused by it were reported globally. The number of people who have survived for five years after making an oncological diagnosis is estimated at 53.5 million people. Tobacco, alcohol, obesity and air pollution remain key drivers of rising cancer rates. Experts believe that by 2050 the number of new cases of cancer will reach 35 million, which will correspond to an increase of 77% compared to 2022. Against this background, the number of operations to remove tumors, including ablation procedures, is increasing, which contributes to the growth of sales of relevant equipment.
 | Cancer rates continue to rise worldwide, creating huge physical, emotional and financial challenges for individuals, entire families, communities and health systems, experts say. |  |
Technological advances that contribute to improving the accuracy and efficiency of tumor ablation systems have a positive impact on the industry. We are talking, in particular, about the introduction of equipment with visual control and the latest HIFU ultrasonic ablation complexes, based on the influence of high-intensity focused ultrasonic waves, without damage to the skin, surrounding tissues and organs.
According to the impact method, the authors of the study segment the market into radiofrequency ablation, microwave ablation, cryoablation, irreversible electroporation, HIFU, etc. In 2024, the largest share of revenue was provided by type one systems - 32.8%. In terms of the mode of intervention, the percutaneous ablation segment was leading, but the highest growth rates are recorded in the laparoscopic ablation region. Geographically, North America dominates with 34.33% of total revenue. At the same time, the Asia-Pacific region shows the highest dynamics. The list of significant industry players on a global scale includes:
- Medtronic;
- Boston Scientific;
- Johnson&Johnson Ethicon Service ( );
- AngioDynamics;
- Bioventus (Misonix);
- EDAP TMS;
- Chongqing Haifu Medical Technology;
- Mermaid Medical;
- HealthTronics;
- H.S. Hospital Service S.p.A.
In 2025, the global tumor ablation equipment market is expected to reach $2.1 billion. Analysts at Grand View Research believe that in the future, the average annual growth rate in complex percentages (CAGR) will be 13.8%. Thus, by 2030, costs may increase to $4.1 billion.[1]
2019: Sales growth to $1.1 billion
At the end of March 2020, Grand View Research published a report on sales of tumor ablation equipment. Experts estimated the volume of this market at $1.1 billion at the end of 2019.
According to the study, radiofrequency ablation has become the most commonly used technique (more than 30%) because it can be effectively used in solid tumors. The main market for sales of ablation equipment has become the United States due to factors such as the increase in cancer prevalence, high purchasing power parity, government support for quality health care and the availability of reimbursement.
The increasing incidence of cancer and the high demand for effective treatment options are the main factors influencing the market. Minimally invasive procedures, including tumor ablation, provide benefits such as rapid recovery, patient comfort and lower time costs. The integration of tumor removal devices with effective imaging techniques such as ultrasound, MRI and CT are expected to revolutionize ablation procedures performed on an outpatient basis. This approach would significantly reduce patient costs, including spending on hospital stays.
Government initiatives, such as screening programs, awareness campaigns and schemes to combat various cancers, allow for an increase in the number of diagnosed cases. Such initiatives increase the need for early-stage cancer treatment, thereby contributing to the demand for ablative therapy devices.
In addition, the increasing demand for advanced medical technologies, their advantages over standard treatment regimens, and integration with imaging techniques contribute to the increased demand for ablative tumor removal devices.[2]
2016: Up to $406 million
In August 2016, the analytical company Mordor Intelligence published the results of a study of the global market for tumor ablation equipment. Its volume, according to experts, will double by 2021.
Analysts expect sales of solutions used to ablate tumors to be measured at $406 million in 2016. In the next five years, the market will grow by an average of 13.5% annually and will reach $765 million by 2021.
The following companies are called the largest manufacturers of tumor ablation devices at Mordor Intelligence:
- AngioDynamics;
- Galil Medical;
- NeuWave Medical;
- Medtronic;
- SonaCare Medical;
- Misonix;
- BVM Medical;
- Comsol;
- Boston Scientific Corporation.
Researchers say Medtronic and Boston Scientific Corporation will be able to show strong growth in the market in 2016-2021.
Specialists distinguish several types of ablation depending on the nature of the destructive agent (radiofrequency and microwave ablation, cryosurgery), the type of procedures (surgical, laparoscopic and percutaneous ablation) and treatment organs (liver, lungs, kidneys).
Radiofrequency ablation (thermal destruction) holds a significant market share due to the highly targeted impact and absence of damage to neighboring cells, but surgical procedures are most often performed (as of August 2016).
The largest market for tumor ablation equipment in 2015 was North America, which accounted for more than 30% of sales due to factors such as increasing cancer prevalence and developed health infrastructure in the region.[3]
Notes
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |